BiotechTube
Home/Indivumed Therapeutics/Prof. Dr. Hartmut Juhl
PD

Prof. Dr. Hartmut Juhl

Founder & CEO

Indivumed Therapeutics

Therapeutic Areas

Oncology

Indivumed Therapeutics Pipeline

DrugIndicationPhase
Undisclosed CRC Program(s)Colorectal CancerPre-clinical